| Title |
Symptom Variability and Early Symptom Regression in the MAPP Study: A Prospective Study of Urological Chronic Pelvic Pain Syndrome
|
|---|---|
| Published in |
The Journal of Urology, April 2016
|
| DOI | 10.1016/j.juro.2016.04.070 |
| Pubmed ID | |
| Authors |
Alisa J. Stephens-Shields, J. Quentin Clemens, Thomas Jemielita, John Farrar, Siobhan Sutcliffe, Xiaoling Hou, J. Richard Landis, J. Quentin Clemens, Philip Hanno, Ziya Kirkali, John W. Kusek, J. Richard Landis, M. Scott Lucia, Robert M. Moldwin, Chris Mullins, Michel A. Pontari, David J. Klumpp, Anthony J. Schaeffer, Apkar Apkarian, David Cella, Melissa A. Farmer, Colleen Fitzgerald, Richard Gershon, James W. Griffith, Charles J. Heckman, Mingchen Jiang, Laurie Keefer, Darlene S. Marko, Jean Michniewicz, Todd Parrish, Frank Tu, Emeran A. Mayer, Larissa V. Rodríguez, Jeffry Alger, Cody P. Ashe-McNalley, Ben Ellingson, Nuwanthi Heendeniya, Lisa Kilpatrick, Cara Kulbacki, Jason Kutch, Jennifer S. Labus, Bruce D. Naliboff, Fornessa Randal, Suzanne R. Smith, Karl J. Kreder, Catherine S. Bradley, Mary Eno, Kris Greiner, Yi Luo, Susan K. Lutgendorf, Michael A. O’Donnell, Barbara Ziegler, Daniel J. Clauw, J. Quentin Clemens, Suzie As-Sanie, Sandra Berry, Clara Grayhack, Megan E. Halvorson, Richard Harris, Steve Harte, Eric Ichesco, Ann Oldendorf, Katherine A. Scott, David A. Williams, Dedra Buchwald, Niloofar Afari, John Krieger, Jane Miller, Stephanie Richey, Kelly Robertson, Susan O. Ross, Roberta Spiro, TJ Sundsvold, Eric Strachan, Claire C. Yang, Gerald L. Andriole, H. Henry Lai, Rebecca L. Bristol, Graham Colditz, Georg Deutsch, Vivien C. Gardner, Robert W. Gereau, Jeffrey P Henderson, Barry A. Hong, Thomas M. Hooton, Timothy J. Ness, Carol S. North, Theresa M. Spitznagle, Siobhan Sutcliffe, Jennifer Anger, Michael Freeman, Jayoung Kim, Karyn Eilber, Jennifer Van Eyk, Wei Yang, Vincent Funari, Jeena Cha, J. Richard Landis, Ted Barrell, Philip Hanno, Ro- Pauline Doe, John T. Farrar, Laura Gallagher, Xiaoling Hou, Thomas Jemielita, Tamara Howard, Michel A. Pontari, Nancy Robinson, Sandra Smith, Alisa Stephens, Yanli Wang, Xingmei Wang, M. Scott Lucia, Adrie van Bokhoven, Andrea A. Osypuk, Robert Dayton, Karen R. Jonscher, Holly T. Sullivan, R. Storey Wilson, Marsha A. Moses, Andrew C. Briscoe, David Briscoe, Adam Curatolo, John Froehlich, Richard S. Lee, Monisha Sachdev, Keith R. Solomon, Hanno Steen, Sean Mackey, Epifanio Bagarinao, Lauren C. Foster, Emily Hubbard, Kevin A. Johnson, Katherine T. Martucci, Rebecca L. McCue, Rachel R. Moericke, Aneesha Nilakantan, Noorulain Noor, J. Curtis Nickel, Garth D. Ehrlich, Chris Mullins, John W. Kusek, Ziya Kirkali, Tamara G. Bavendam |
| Abstract |
We examine symptom variability in men and women with urological chronic pelvic pain syndrome (UCPPS). We describe symptom fluctuations as related to early symptom regression and its effect on estimated one-year symptom change. We then describe a method to quantify patient-specific symptom variability. Symptoms were assessed biweekly in 424 UCPPS subjects over one year. Subjects were classified as 'improved', 'no change', or 'worse' according to their rate of change using 1) all data, 2) excluding week 0, and 3) excluding weeks 0 and 2 to evaluate the impact of early symptom regression. Patient-specific time-varying variability was calculated at each interval using a sliding window approach. Patients were classified as high, medium, or low variability at each time and ultimately as high or low variability overall based on their variability for the majority of contacts. Prior to excluding early weeks to adjust for early symptom regression 25-38% and 5-6% of patients were classified as improved and worse, respectively; after adjustment the percentage of patients improved or worse ranged from 15-25% and 6-9%. 'High and 'low' variability phenotypes were each identified in 25-30% of participants. Patients with UCPPS exhibit symptom variability. At enrollment, patients had, on average, worse symptoms, resulting in a regression effect that influenced the estimated proportion of improved or worse subjects. Prospective studies should include a run-in to account for regression to the mean and other causes of early symptom regression. Further, symptom variability may be quantified and used to characterize longitudinal UCPPS symptom profiles. |
Login to access the Attention Digest and the Sentiment Analysis related to this output.
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 75% |
| France | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 58 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 13 | 22% |
| Researcher | 9 | 16% |
| Professor | 6 | 10% |
| Student > Doctoral Student | 4 | 7% |
| Professor > Associate Professor | 4 | 7% |
| Other | 11 | 19% |
| Unknown | 11 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 33% |
| Neuroscience | 7 | 12% |
| Psychology | 4 | 7% |
| Social Sciences | 4 | 7% |
| Nursing and Health Professions | 3 | 5% |
| Other | 4 | 7% |
| Unknown | 17 | 29% |